Mostrando 3 resultados de: 3
Filtros aplicados
Publisher
Expert Opinion on Investigational Drugs(1)
Expert Review of Neurotherapeutics(1)
Neurologia(1)
Origen
scopus(3)
Masitinib for the treatment of mild to moderate Alzheimer's disease
ReviewAbstract: Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of dePalabras claves:ALZHÉIMER, inflammation, masitinib, Neurodegeneration, TauAutores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Lazarowski A., Miguel Marin, Olloquequi J., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusMavoglurant as a treatment for Parkinson's disease
ReviewAbstract: Introduction: A major unresolved issue in the Parkinson's disease (PD) treatment is the developmentPalabras claves:L-Dopa, Mavoglurant, Mlgu5, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., De Lemos M.L., Folch J., Lazarowski A., Pallás M., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusReview of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein
OtherAbstract: Introduction Alzheimer disease (AD) is a major neurodegenerative disorder which eventually results iPalabras claves:Alzheimer disease, Amyloid hypotheses, Beta-amyloid, Beta-secretase, Gamma-secretaseAutores:Abad S., Antoni Camins, Ettcheto M., Folch J., Miguel Marin, Olloquequi J., Pedros I., Petrov D.Fuentes:scopus